Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05096754 · ClinicalTrials.gov registry record
OCS Liver PROTECT Continued Access Protocol (CAP) Continuation Post-Approval Study
A clinical trial of Liver Transplant, sponsored by TransMedics.
- Completed
- Registry status
- 74
- Enrollment target
- 11
- Study locations
NCT05096754 is a study of Liver Transplant that has completed, run by TransMedics. The registered enrollment target is 74 participants, below the 5,454-participant average among 19 other Liver Transplant trials with a reported enrollment target (99% lower). The trial reports 11 study locations across 7 states.
The verdict
NCT05096754, a study of Liver Transplant, has completed, sponsored by TransMedics.
- COMPLETED
- Registry status
- 74 participants
- Enrollment target
- 11
- Study locations
Study Summary
Post-approval observational study of subjects that were enrolled and transplanted in the OCS Liver PROTECT CAP.
Conditions Studied
Interventions
- DEVICE OCS Liver
Study Locations (11)
California
- Scripps - La Jolla
- University of California San Diego - La Jolla
- University of California San Francisco - San Francisco
Texas
- University of Texas Southwest - Dallas
- Houston Methodist Hospital - Houston
- The University of Texas Health Science Center at San Antonio - San Antonio
Maryland
- Johns Hopkins - Baltimore
Massachusetts
- Massachusetts General Hospital - Boston
Nebraska
- University of Nebraska Medical Center - Omaha
New York
- Mount Sinai - New York
Virginia
- Virginia Commonwealth University Health System - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2020-02-03 |
| Est. Completion | 2023-02-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05096754
The ClinicalTrials.gov registry entry for NCT05096754 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,454-participant average among 19 other Liver Transplant trials with a reported enrollment target (99% lower). The listed sponsor is TransMedics, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Liver Transplant appearing as the primary indexed condition, and to 1 intervention - of which OCS Liver is the first listed.
NCT05096754 reports 11 study locations spanning 7 distinct geographic areas - top geographies include California, Texas, Maryland.
Frequently Asked Questions
What is clinical trial NCT05096754 about?
NCT05096754 is a clinical study titled "OCS Liver PROTECT Continued Access Protocol (CAP) Continuation Post-Approval Study". Post-approval observational study of subjects that were enrolled and transplanted in the OCS Liver PROTECT CAP.
What is the current status of trial NCT05096754?
This trial is currently completed. The enrollment target is 74 participants. The study started on 2020-02-03. Estimated completion is 2023-02-02.
What conditions does trial NCT05096754 study?
This clinical trial studies the following conditions: Liver Transplant.
What interventions are being tested in trial NCT05096754?
The interventions under investigation include: OCS Liver (DEVICE).
Who is sponsoring clinical trial NCT05096754?
This trial is sponsored by TransMedics, which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05096754 being conducted?
This trial has 11 study locations across California, Maryland, Massachusetts, Nebraska, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver Transplant
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Expanding Liver Transplant Immunosuppression Minimization Via Everolimus
RECRUITING · Phase 2
-
US National OCS Liver Perfusion (OLP) Registry
RECRUITING
-
Liver Transplant CGM
RECRUITING
-
Auriculo-Nerve Stimulation on Post-Operative Opioid Requirement
RECRUITING · NA
-
Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates
RECRUITING · Phase 2
-
EVR and EPO for Liver Transplant Tolerance
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.